EP2993133B1 - Installation et procédé de changement d'emballage de différents médicaments à partir de leur blister transparent dans des blisters de remplissage - Google Patents

Installation et procédé de changement d'emballage de différents médicaments à partir de leur blister transparent dans des blisters de remplissage Download PDF

Info

Publication number
EP2993133B1
EP2993133B1 EP14183954.8A EP14183954A EP2993133B1 EP 2993133 B1 EP2993133 B1 EP 2993133B1 EP 14183954 A EP14183954 A EP 14183954A EP 2993133 B1 EP2993133 B1 EP 2993133B1
Authority
EP
European Patent Office
Prior art keywords
blister
blister pack
original
medicines
packs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Not-in-force
Application number
EP14183954.8A
Other languages
German (de)
English (en)
Other versions
EP2993133A1 (fr
Inventor
Edwin Kohl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to ES14183954.8T priority Critical patent/ES2626779T3/es
Priority to EP14183954.8A priority patent/EP2993133B1/fr
Priority to US15/509,482 priority patent/US20170253353A1/en
Priority to PCT/EP2015/070125 priority patent/WO2016037923A1/fr
Priority to CA2960322A priority patent/CA2960322A1/fr
Publication of EP2993133A1 publication Critical patent/EP2993133A1/fr
Application granted granted Critical
Publication of EP2993133B1 publication Critical patent/EP2993133B1/fr
Not-in-force legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B1/00—Packaging fluent solid material, e.g. powders, granular or loose fibrous material, loose masses of small articles, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
    • B65B1/04—Methods of, or means for, filling the material into the containers or receptacles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B5/00—Packaging individual articles in containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, jars
    • B65B5/10—Filling containers or receptacles progressively or in stages by introducing successive articles, or layers of articles
    • B65B5/101—Filling containers or receptacles progressively or in stages by introducing successive articles, or layers of articles by gravity
    • B65B5/103—Filling containers or receptacles progressively or in stages by introducing successive articles, or layers of articles by gravity for packaging pills or tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • A61J1/035—Blister-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B35/00—Supplying, feeding, arranging or orientating articles to be packaged
    • B65B35/10—Feeding, e.g. conveying, single articles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B57/00—Automatic control, checking, warning, or safety devices

Definitions

  • the invention relates to a system and a method for repackaging of different drugs from their respective Originalblisterverpackungs in Be Shellblister, especially patient-specific Wegblister having arranged in matrix configuration receiving compartments with rows corresponding to a number of times during a day and columns corresponding to a number of days, such as days of the week.
  • the DE 10 2004 034 024 A2 is an individual blister pack for the weekly drug needs of a patient (weekly blister) known to take the medication in a order by date, day of the week and time of day (morning, noon and evening and / or night) ordered.
  • the receiving compartments of the blister pack for receiving the respective medicaments are arranged in matrix form with seven daily columns, each with at least three time-of-day compartments, which are closed overall by a continuous blister foil.
  • Affixed to the blister pack is a carton-shaped lid, on which the patient-individual the composition of the individual time of day subjects as well as prescription information concerning the respective medicaments is contained.
  • Such weekly blister packs are for patients who regularly need to take several different drugs, a help not only to remember the intake of important medications and on the other hand to keep a reliable overview of what medications are already taken to avoid a potentially harmful over-medication ,
  • WO 2005 102 841 A1 is a system for equipping such patient-specific blister packs with the desired drug composition known.
  • a dispensing station For each drug, a dispensing station is provided which conveys the medicaments from a temporary package in the form of a strip blister into the corresponding receiving compartments of the packaging unit by spatulas associated with the receiving compartments of the blister pack. All patient-specific blister packs cyclically pass through all the dispensing stations of the system, whereby only at those stations medications are taken which correspond to the prescription data associated with the individual blister pack. In this way, patient-specific packaging units can be filled automatically and safely with a selection of several hundred drugs.
  • the EP 2 754 615 describes a system and a method for patient-specific placement of Be colllblistern with medication according to prescribed prescription data, wherein the Be collllblister individually one behind the other in a direction of movement along several successively arranged drug filling stations for loading the Behellblister each with a specific drug and each Be sapllblister is controlled individually so that it only the respective required according to the prescription data required drug filling stations for a filling and the other drug filling stations happens.
  • the object is achieved by a method for repackaging a variety of different drugs from their respective original blisters in Be Shellblister comprising the process steps: assignment of the filled with drug blisters to a blister carrier provided for the respective original blister carrier with standardized outer dimensions, packaging the filled with drugs Originalblister in the assigned Blister support, intermediate storage of the blister packs in a blister pack, upon request, removal of the original blister of a selected one of the plurality of medicaments from the blotter, and ejection of a defined number of units of the selected medicament from the blister to the blister.
  • the object is further achieved by the system for repackaging a variety of different drugs from their respective original blisters in Be Shellblister, comprising a conveyor for separating and feeding of filled original blisters, designed as a drawer storage intermediate storage with random access to the intermediate storage of the original blister, packaged in for a respective Originalblistertyp associated blister carrier with standardized outer dimensions, and an ejector for ejecting a defined number of units of a selected drug from the respective original blister in the Be colllblister.
  • the invention thus allows the operation of a single drug filling station, which is able to fill Be Pavllblister patient-individually controlled with several different drugs.
  • the intermediate storage of the medication in their original blister packs allows a maximum storage time.
  • the blister carriers with standardized outer dimensions assigned to the respective types of medication enable efficient storage, handling and safe deflaking of the original blister packs.
  • a deblistering device with a plurality of different medicament ejection tappets may preferably be provided which are each adapted to a specific medicament and / or original blister form and / or the openings of the blister carrier.
  • the different drug ejection rams are preferably rotatably mounted on an axis for random access.
  • the Entblistanss Paind arthritis may have a perforation device for perforation of the blister foil in the blister zones of the ejected drugs of the original blister.
  • the original blister remains in the blister carrier during the drug ejection process, the blister being placed in an orientation with blistering stations facing down on the blister carrier, and the medicaments withdrawn from the blisters in reverse orientation with blistering upwardly facing blisters.
  • the drugs are ejected from the original blister in a pre-metering magazine and transported from there in a temporally decoupled second step in the Be Stirllblister.
  • the time-critical process of filling the Be Glallblisters is decoupled from the mechanically difficult process of expelling the drugs from the original blister.
  • optical sensor means are provided for checking the proper discharge of the selected drugs from the original blister into the pre-metering magazine and / or the correct placement of the inflation blisters.
  • Partially filled original blisters are preferably stored together with blister carrier in the intermediate storage and completely emptied blisters are disposed of accordingly.
  • the apparatus and method of the invention serve to repackage a larger number (e.g., 100) of various medicaments, typically supplied in a variety of molded original blister packs.
  • the individual medicines are delivered in their original packaging and the blister packs are manually or mechanically removed and separated from the respective outer packagings (not shown).
  • the individualized original blister packs 10 are then assigned to suitable blister carriers 20, which correspond to the packaging and storage of the different medicaments in their respective original blister packs 10 in the intermediate storage 50 according to the invention.
  • Figures 1A and 1B serve.
  • blister carriers 20 are provided for all desired types of medication, wherein different drugs with similarly shaped original blister packs 10 can be assigned to identical blister carriers 20. It is important that the outer dimensions of all blister carrier 20 standardized, preferably identical.
  • a blister carrier 20 comprises a carrier part 21 and a lid part 22 hinged by means of a hinge connection 24 or the like.
  • Carrier part 21 and cover part 22 both have a hole pattern 23 coordinated with the respective original blister pack 10.
  • the original blister pack 10 with the film side up on the hole pattern 23 of the support member 21 of the blister carrier 20, as shown in FIG FIG. 2 is illustrated.
  • the hole pattern 23 takes on the Blisterhöfe 12 of the original blister 10.
  • the lid member 22 is closed, as in FIG. 3 is illustrated.
  • the outer dimensions of the blister carrier 20 are preferably all identical, so that they can be stored and transported efficiently in the intermediate storage 50.
  • Each blister carrier 20 also has an identification device 27, such as an RFID chip 27 (FIG. FIG. 4 ) for identifying the drug stored in the blister carrier 20.
  • FIG. 1B shows the drawer storage 50 with an extended drawer 52.
  • the drawer storage 50 allows optional access to each of the stored therein blister carrier 20 with it in the respective original blister 10 packaged drugs.
  • the control technique determines the position of the desired medicament packaged in one of the blister carriers 20, which is removed from the drawer bearing 50 by means of the actuator 54 and conveyed on the conveyor line 66 by a carriage 68 the Entblist mecanics owned 80 is fed, which schematically in FIG. 4 is shown.
  • the blister carrier 20 arrives at the deflagration position where the medicaments 15 are successively ejected into the compartments 74 of a pre-metering magazine 70 by means of a suitable ejection ram 82. As in FIG.
  • the shape of the ejection ram 82 is optimized for the smooth ejection of the medicaments 15 from the respective original blister packs 10 and in particular adapted to the shape of the openings 23 of the blister carrier 20 used, the shape of the medicaments 15 and / or the shape of the blister stations 12 of the original blister 10.
  • the deblistering device 70 preferably has a perforation device 95 which is schematically illustrated in FIG FIG. 5 is shown and the film of the original blister 10 perforated at the positions of Blisterhöfe. Such a perforation is schematically designated by the reference numeral 11.
  • the pre-metering magazine 70 of the illustrated embodiment of the invention has seven pre-metering compartments 72 corresponding to the seven weekday columns of the filling blister 40, whereby according to the invention a different number of compartments 72 is also possible.
  • Slits are preferably provided in the lower region of the side walls of the predosing compartments 72 for optically checking whether or not there is a medicament in the respective predosing compartment 72.
  • the medicaments are dispensed from the pre-metering compartments 72 of the pre-metering magazine 70 into the corresponding compartments 42 of the patient-individual filling blister 40, as in FIG FIG. 6 is shown schematically.
  • the pre-metering magazine 70 is positioned above the respective (time of day) line of the filling blister 40 and the medicaments 15 are thrown off into the respective receiving compartments 42 of the filling blister 40 by pushing back the bottom part 74 of the predosing compartments 72.
  • the Be colllblister 40 has arranged in matrix configuration receptacles 42 which are arranged in the illustrated embodiment in four lines corresponding to a number of intake times during a day (morning, noon, evening, night) and seven columns corresponding to the days of a week.
  • the invention is not limited to this particular arrangement of the receiving compartments 42 of the Be colllblisters.
  • Sensor devices 90, 92 are furthermore preferably provided which check the transfer of the medicaments from the original blister pack 10 into the predosing magazine 70 and further into the temporary compartments 42 of the filling blister 40 and generate an error message in the event of an error.
  • An embodiment of the method according to the invention for personal placement of Be Pavllblistern is schematically in the flowchart of FIG. 7 fauxgefsst.
  • a first method step S1 the medicaments contained in the original blister are assigned to a specific blister carrier, packed in this blister carrier in method step S3 and temporarily stored in the intermediate storage in the subsequent method step S5.
  • step S7 a selected one of the intermediately stored medicaments is then removed from the intermediate storage facility and fed to the deflaking device, where it is ejected in process step S8 into the pre-metering magazine.
  • the selected medicaments are dispensed from the pre-metering magazine into the corresponding compartments of the filling blister. It should be noted that the use of the pre-metering magazine is advantageous, but the invention is not limited thereto.
  • the invention thus makes it possible, at a single medication filling station, to fill inflation blisters in a patient-controlled manner with a plurality of different medicaments.
  • the storage of the medication in the intermediate storage in the original blisters allows a maximum storage time.
  • the storage of the (partially) filled original blisters takes place with the help of assigned blister carriers with standardized outer dimensions, which allow an efficient storage, handling and blistering of the original blisters.
  • the optional use of the pre-metering magazine 70 in the placement system according to the invention ensures that the ejection process from the original blister 10 and the loading process of the filling blister 40 are decoupled from one another.
  • the time-critical filling process of the filling blister 40 with respect to speed can be optimized for the performance of the overall system, while more time is available for the mechanically difficult ejection process from the original blister 10 without impairing the performance of the overall system.

Landscapes

  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medical Informatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Claims (16)

  1. Procédé de reconditionnement d'une multiplicité de médicaments différents à partir de leurs blisters d'origine (10) respectifs dans des blisters à remplir (40), ce procédé présentant les étapes de procédé suivantes :
    - affectation des blisters d'origine (10) remplis de médicaments à un support de blisters (20) prévu pour le type de blisters d'origine respectif muni de dimensions extérieures normalisées,
    - emballage des blisters d'origine (10) remplis de médicaments dans le support de blisters (20) affecté,
    - stockage intermédiaire dans un magasin intermédiaire (50) des blisters d'origine emballés dans les supports de blisters (20),
    - sur demande, enlèvement, à partir du magasin intermédiaire (50), du blister d'origine (10), emballé dans le support de blisters (20), d'un médicament sélectionné parmi la multiplicité de médicaments,
    - éjection, à partir du blister d'origine et dans le blister à remplir (40), d'un nombre défini d'unités du médicament sélectionné.
  2. Procédé selon la revendication 1, les supports de blisters (20) présentant respectivement une partie de support (21) avec un certain nombre d'ouvertures (23) pour la réception des poches de blister (12) du blister d'origine (10), une partie de couverture (22) avec le même nombre d'ouvertures (23) en tant qu'ouvertures d'éjection pour les médicaments emballés dans le blister d'origine, et un système d'identification (27) pour l'identification du support de blisters (20) respectif.
  3. Procédé selon la revendication 2, les supports de blisters (20) présentant différents motifs d'ouvertures (23) pour la réception de différents blisters d'origine (10).
  4. Procédé selon l'une des revendications 1 à 3, le blister d'origine (10) demeurant dans le support de blisters (20) pendant le processus d'éjection de médicaments.
  5. Procédé selon la revendication 4, le blister d'origine (10) étant placé sur le support de blisters (20) dans une orientation avec des poches de blister (12) dirigées vers le bas, et les médicaments étant éjectés hors des blisters d'origine (10) dans une orientation inverse avec des poches de blister (12) dirigées vers le haut.
  6. Procédé selon l'une des revendications 1 à 5, les médicaments étant éjectés du blister d'origine (10) vers un chargeur de pré-dosage (70) et transportés de là dans le blister à remplir (40) dans une deuxième étape de procédé découplée dans le temps.
  7. Procédé selon l'une des revendications 1 à 6, comprenant l'étape de procédé de retour en stock de blisters d'origine (10) encore partiellement remplis conjointement avec le support de blisters (20) dans le magasin intermédiaire (50) tandis que des blisters d'origine (10) entièrement vidés sont évacués.
  8. Procédé selon l'une des revendications 1 à 7, les blisters à remplir (40) étant remplis avec des médicaments conformément à des données de prescription prédéfinies personnelles au patient, et les blisters à remplir (40) présentant, pour des unités d'administration de médicaments respectives, des cases de réception (42) disposées dans une configuration matricielle en lignes correspondant à un nombre d'heures de prises pendant une journée et en colonnes correspondant à un nombre de jours, par exemple de jours de la semaine.
  9. Installation de reconditionnement d'une multiplicité de différents médicaments à partir de leurs blisters d'origine (10) respectifs dans des blisters à remplir (40), présentant un système de transport (60) pour la séparation et l'acheminement de blisters d'origine (10) remplis, un magasin intermédiaire (50), constitué en tant que magasin à tiroirs, avec un accès sélectif pour le stockage intermédiaire de blisters d'origine (10), ayant des dimensions extérieures normalisées, emballés dans des supports de blisters (20) affectés à un type de blister d'origine respectif, et un système d'éjection (80) pour l'éjection dans le blister à remplir (40) d'un nombre défini d'unités d'un médicament sélectionné à partir du blister d'origine (10) respectif.
  10. Installation selon la revendication 9, les supports de blisters (20) présentant respectivement une partie de support (21) avec un certain nombre d'ouvertures (23) pour la réception des poches de blister du support de blisters (20), une partie de couverture (22) avec le même nombre d'ouvertures en tant qu'ouvertures d'éjection pour les médicaments emballés dans le blister d'origine (10), et un système d'identification (27) pour l'identification du support de blisters (20) respectif.
  11. Installation selon la revendication 10, les supports de blisters (20) présentant différents motifs d'ouvertures (23) pour la réception de blisters d'origine (10) différents.
  12. Installation selon la revendication 11, présentant un système de déconditionnement des blisters (80) avec une pluralité de poussoirs d'éjection de médicaments (82) différents qui sont respectivement adaptés à une forme définie de médicaments et/ou de blisters d'origine et/ou aux ouvertures (23) du support de blisters (20).
  13. Installation selon la revendication 12, la pluralité de poussoirs d'éjection de médicaments (82) différents étant supportée en rotation sur un axe pour l'accès sélectif.
  14. Installation selon l'une des revendications 9 à 13, présentant un système de perforation (95) pour la perforation de la pellicule de blister dans la zone des poches de blister (12) des médicaments du blister d'origine (10) devant être éjectés.
  15. Installation selon l'une des revendications 9 à 14, les médicaments étant éjectés du blister d'origine vers un chargeur de pré-dosage et transportés de là vers le blister à remplir (40) dans une deuxième étape de procédé découplée dans le temps.
  16. Installation selon la revendication 15, présentant des systèmes de capteur optiques (90, 92) pour la vérification de l'éjection correcte des médicaments sélectionnés à partir du blister d'origine (10) vers le chargeur de pré-dosage (70) et/ou du garnissage correct des blisters à remplir (40).
EP14183954.8A 2014-09-08 2014-09-08 Installation et procédé de changement d'emballage de différents médicaments à partir de leur blister transparent dans des blisters de remplissage Not-in-force EP2993133B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
ES14183954.8T ES2626779T3 (es) 2014-09-08 2014-09-08 Instalación y procedimiento para el reenvasado de diferentes medicamentos desde sus blísteres originales respectivos a blísteres de llenado
EP14183954.8A EP2993133B1 (fr) 2014-09-08 2014-09-08 Installation et procédé de changement d'emballage de différents médicaments à partir de leur blister transparent dans des blisters de remplissage
US15/509,482 US20170253353A1 (en) 2014-09-08 2015-09-03 Installation and method for repackaging different medicines from their respective original blister packs into organiser blister packs
PCT/EP2015/070125 WO2016037923A1 (fr) 2014-09-08 2015-09-03 Système et procédé de reconditionnement de différents médicaments hors de leurs emballages-coques respectifs d'origine dans des emballages-coques à remplir
CA2960322A CA2960322A1 (fr) 2014-09-08 2015-09-03 Installation et methodes de reconditionnement de differents medicaments de leurs emballages-coques originaux dans des emballages-coques de pilulier

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14183954.8A EP2993133B1 (fr) 2014-09-08 2014-09-08 Installation et procédé de changement d'emballage de différents médicaments à partir de leur blister transparent dans des blisters de remplissage

Publications (2)

Publication Number Publication Date
EP2993133A1 EP2993133A1 (fr) 2016-03-09
EP2993133B1 true EP2993133B1 (fr) 2017-03-29

Family

ID=51564457

Family Applications (1)

Application Number Title Priority Date Filing Date
EP14183954.8A Not-in-force EP2993133B1 (fr) 2014-09-08 2014-09-08 Installation et procédé de changement d'emballage de différents médicaments à partir de leur blister transparent dans des blisters de remplissage

Country Status (5)

Country Link
US (1) US20170253353A1 (fr)
EP (1) EP2993133B1 (fr)
CA (1) CA2960322A1 (fr)
ES (1) ES2626779T3 (fr)
WO (1) WO2016037923A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3135602A1 (fr) * 2015-08-25 2017-03-01 Bayer Pharma Aktiengesellschaft Blister
CN108938286B (zh) * 2018-09-05 2020-09-22 佳木斯大学 一种用于护理科室的药品手推车
WO2023194542A1 (fr) 2022-04-08 2023-10-12 Knapp Ag Support de comprimés pour le transport intermédiaire de comprimés lors d'un processus de conditionnement sous emballage-coque, dispositif de remplissage pour un support de comprimés et procédé de remplissage d'un support de comprimés
EP4273060A1 (fr) 2022-04-08 2023-11-08 Knapp AG Procédé de fonctionnement d'un dispositif d'emballage pour re-emballer des médicaments se présentant sous forme de comprimés et procédé de fonctionnement d'un dispositif d'emballage
WO2023194555A1 (fr) 2022-04-08 2023-10-12 Knapp Ag Procédé pour faire fonctionner un dispositif de suremballage destiné à suremballer des médicaments présents sous la forme de comprimés et procédé pour faire fonctionner un dispositif de suremballage
DE102022114115A1 (de) 2022-04-08 2023-10-12 Knapp Ag Tablettenträger zum Zwischentransport von Tabletten in einem Verblisterungsprozess, Befüllvorrichtung für einen Tablettenträger und Verfahren zum Befüllen eines Tablettenträgers
DE102022114943B4 (de) 2022-04-08 2024-04-11 Knapp Ag Umverpackungsvorrichtung zum Umverpacken von in Tablettenform vorliegenden Medikamenten und Verfahren zum Betreiben einer Umverpackungsvorrichtung

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002255256A (ja) * 2001-02-28 2002-09-11 Yoshino Kogyosho Co Ltd Ｐｔｐシート用ケース
FR2845668B1 (fr) * 2002-10-14 2005-08-05 Sanofi Synthelabo Etui de protection d'un blister realise en matiere plastique rigide
DE102004020510B4 (de) 2004-04-26 2007-11-29 Edwin Kohl Anlage zur Bestückung von Verpackungseinheiten mit dem verordnungsgemäßen Wochenbedarf von Patienten entsprechenden Medikamenten
DE102004034024A1 (de) 2004-04-26 2006-02-09 Klingel, Hans, Dr.-Ing. h.c. Verpackungseinheit für den wöchentlichen Medikamentenbedarf eines Patienten
US7784244B2 (en) * 2007-08-13 2010-08-31 Mts Medication Technologies, Inc. High speed automated filling of solid pharmaceutical product packaging via a conveyor system
US7950206B2 (en) * 2008-06-27 2011-05-31 Qem, Inc. Pill dispenser with canisters having electronically readable/writeable identification
EP2754615B1 (fr) 2013-01-14 2015-07-29 Edwin Kohl Installation destinée au garnissage pour une personne de blisters avec des médicaments selon des informations de prescription prédéfinies

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Also Published As

Publication number Publication date
US20170253353A1 (en) 2017-09-07
WO2016037923A1 (fr) 2016-03-17
CA2960322A1 (fr) 2016-03-17
EP2993133A1 (fr) 2016-03-09
ES2626779T3 (es) 2017-07-26

Similar Documents

Publication Publication Date Title
EP2993133B1 (fr) Installation et procédé de changement d'emballage de différents médicaments à partir de leur blister transparent dans des blisters de remplissage
EP2754614B1 (fr) Installation et procédé destinés au remplissage pour une personne de blisters avec des médicaments
EP1966066B1 (fr) Systeme de stockage automatise et procede de stockage et de distribution de medicaments
EP2754615B1 (fr) Installation destinée au garnissage pour une personne de blisters avec des médicaments selon des informations de prescription prédéfinies
EP1740459B1 (fr) Installation pour remplir des unites d'emballage avec des medicaments, en fonction des besoins hebdomadaires de patients definis par une prescription medicale
EP1973511B1 (fr) Installation de production automatique d'emballages de produits medicaux et/ou pharmaceutiques et/ou de complements alimentaires
WO1998029084A1 (fr) Procede et dispositif de distribution automatique d'objets individuels, notamment d'une pilule individuelle
EP2000410B1 (fr) Procédé de fabrication d'emballages de plusieurs jours avec divers médicaments
EP2062822A1 (fr) Procédé et dispositif de remplissage individuel de blisters
EP1947027A1 (fr) Habillage transparent et procédé de stockage temporaire de produits
EP3266718B1 (fr) Machine d'emballage comprenant un dispositif de stockage temporaire pour des produits pharmaceutiques emballés
EP2818420B1 (fr) Procédé de remplissage sécurisé d'une boîte de transport présentant une pluralité de surfaces de réception en utilisant une station d'entrée/sortie mettant à disposition de façon séquentielle des emballages de médicament provenant d'un stock automatisé et station d'entrée/sortie correspondante
DE102008047975B4 (de) Vorrichtung zur individuellen Zusammenstellung von Tabletten
EP2092927A1 (fr) Procédé de commissionnement en fonction des besoins de portions de médicaments dans des emballages de distribution
WO2016110528A1 (fr) Dispositif de préparation de commandes et procédé de stockage de marchandises avec le dispositif de préparation de commandes
EP3081500B1 (fr) Dispositif de fabrication de blister souple
EP2955116B1 (fr) Dispositif et procédé de guidage de produits dans des jattes de plaquettes thermoformées
DE202012010933U1 (de) Nachlegevorrichtung für Packungen in einer Verpackungslinie
DE102022114943B4 (de) Umverpackungsvorrichtung zum Umverpacken von in Tablettenform vorliegenden Medikamenten und Verfahren zum Betreiben einer Umverpackungsvorrichtung
DE102014008692A1 (de) Vorrichtung zur automatischen Tablettenausgabe
WO2023194555A1 (fr) Procédé pour faire fonctionner un dispositif de suremballage destiné à suremballer des médicaments présents sous la forme de comprimés et procédé pour faire fonctionner un dispositif de suremballage
EP4273060A1 (fr) Procédé de fonctionnement d'un dispositif d'emballage pour re-emballer des médicaments se présentant sous forme de comprimés et procédé de fonctionnement d'un dispositif d'emballage
DE102011118533A1 (de) Schalenverschließmaschinen mit zwei Siegelstationen
DE4014232A1 (de) Vorrichtung zum verpacken von flaeschchen
DE102009017869B3 (de) Verfahren zum individuellen Zusammenstellen von Tabletten sowie Vorrichtung zur Durchführung des Verfahrens

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

17P Request for examination filed

Effective date: 20160909

RBV Designated contracting states (corrected)

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20161213

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

Free format text: NOT ENGLISH

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 879510

Country of ref document: AT

Kind code of ref document: T

Effective date: 20170415

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

Free format text: LANGUAGE OF EP DOCUMENT: GERMAN

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 502014003188

Country of ref document: DE

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2626779

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20170726

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170329

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170630

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170329

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170329

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170629

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20170329

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170329

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170329

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170329

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170629

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170329

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170329

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170329

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170329

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170329

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20170930

Year of fee payment: 4

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170329

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170329

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170729

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 502014003188

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170329

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20180103

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 502014003188

Country of ref document: DE

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170329

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170329

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20170930

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170908

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20180531

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170908

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180404

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170930

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170930

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171002

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170930

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170329

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20181017

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170909

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20180908

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20140908

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180908

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170329

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180908

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170329

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170329

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170329

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170329

REG Reference to a national code

Ref country code: AT

Ref legal event code: MM01

Ref document number: 879510

Country of ref document: AT

Kind code of ref document: T

Effective date: 20190908

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190908